Concepedia

Maryse Delehedde

MD

Statistics

Publications

41

Citations

2.5K

H-Index

28

Active since

1995

Affiliations

Inserm(Current)

University of Liverpool

Université de Lille

Institut Pasteur de Lille

University of Manchester

Maryse Delehedde is an author at Inserm specializing in medicine, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

1995–2022

41

Publications

41

Endocan Is a Novel Chondroitin Sulfate/Dermatan Sulfate Proteoglycan That Promotes Hepatocyte Growth Factor/Scatter Factor Mitogenic Activity

David Béchard, Thibaut Gentina, Maryse Delehedde et al. · Journal of Biological Chemistry · 2001 · 235 citations · Full text

Interactions of Multiple Heparin Binding Growth Factors with Neuropilin-1 and Potentiation of the Activity of Fibroblast Growth Factor-2

David C. West, C. Rees, Laurence Duchesne et al. · Journal of Biological Chemistry · 2005 · 168 citations · Full text

Vascular endocan (ESM‐1) is markedly overexpressed in clear cell renal cell carcinoma

Xavier Leroy, Sébastien Aubert, Laurent Zini et al. · Histopathology · 2009 · 152 citations · Full text

Differential Effects of Heparin Saccharides on the Formation of Specific Fibroblast Growth Factor (FGF) and FGF Receptor Complexes

Olga Ostrovsky, Bluma Berman, John T. Gallagher et al. · Journal of Biological Chemistry · 2002 · 139 citations · Full text

Fibroblast growth factor-2 binds to small heparin-derived oligosaccharides and stimulates a sustained phosphorylation of p42/44 mitogen-activated protein kinase and proliferation of rat mammary fibroblasts

Maryse Delehedde, Malcolm Lyon, John T. Gallagher et al. · Biochemical Journal · 2002 · 116 citations · Full text

, , +21

1–5 of 41